Physician

Aaron Diodato, D.O.

According to 2025 Medicare claims, Aaron Diodato, D.O. (NPI: 1396705844) practices nephrology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is NEPHROLOGY HYPERTENSION SPECIALISTS (NPI: 1669426342; TIN: 232912285) and primary practice location at 18901-2554.

Diodato's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 376 traditional Medicare patients, billed 1,367 HCPCS/CPT codes, and received $106,160 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,307 prescription claims across 242 beneficiaries totaling $96,685 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 46 claims. Open Payments data shows 52 records totaling $1,194. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $149,372 to $106,160. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	405	2,927	$149,372
2016	414	2,298	$155,801
2017	433	2,403	$213,677
2018	425	1,732	$174,680
2019	451	1,928	$165,313
2020	394	1,541	$137,006
2021	416	1,661	$147,911
2022	415	1,493	$123,329
2023	384	1,356	$112,760
2024	376	1,367	$106,160

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	239	1,477	$77,026
2016	255	1,558	$85,349
2017	271	1,704	$89,803
2018	219	1,427	$60,400
2019	205	1,155	$65,523
2020	212	1,232	$47,050
2021	208	1,137	$49,553
2022	197	1,034	$48,402
2023	214	1,176	$95,080
2024	242	1,307	$96,685

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	128	$12,056
2016	N/R	99	$10,937
2017	N/R	114	$5,297
2018	N/R	39	$1,434
2019	N/R	70	$7,892
2020	N/R	39	$5,739
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$1,253
2024	N/R	46	$348

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	22	22	$164
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	132	146	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	222	372	$71
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	131	551	$63
90935	Hemodialysis procedure with physician evaluation	32	130	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	33	2,550	$45,969
Eplerenone	Eplerenone	29	2,550	$2,281
Valsartan	Valsartan	43	3,270	$2,274
Sevelamer Carbonate	Sevelamer Carbonate	30	1,080	$2,185
Labetalol Hcl	Labetalol Hcl	61	3,270	$2,181

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	22	$251
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	24	$97

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$1,194	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Diodato, D.O.?

Tedicare shows public-source Medicare data for Aaron Diodato, D.O. (NPI 1396705844), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Diodato, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron Diodato, D.O.?

Aaron Diodato, D.O. is linked to NEPHROLOGY HYPERTENSION SPECIALISTS (billing NPI 1669426342) in the available physician profile data.

Does Aaron Diodato, D.O. have Open Payments data?

Aaron Diodato, D.O. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.